Search details
1.
Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?
Cancer Invest
; 41(1): 93-100, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36239419
2.
Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
World J Urol
; 40(10): 2489-2497, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35916904
3.
The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma.
Urol Int
; 106(11): 1168-1176, 2022.
Article
in English
| MEDLINE | ID: mdl-35654002
4.
Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.
Int J Clin Oncol
; 26(11): 2151-2160, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34318390
5.
[Diagnosis and therapy of tumors with NTRK gene fusion]. / Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen.
Pathologe
; 42(1): 103-115, 2021 Feb.
Article
in German
| MEDLINE | ID: mdl-33258061
6.
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Future Oncol
; 16(29): 2307-2328, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32964728
7.
Bevacizumab-associated glomerular microangiopathy.
Mod Pathol
; 32(5): 684-700, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30552416
8.
Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma.
Liver Int
; 39(4): 714-726, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30663219
9.
Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center.
Future Oncol
; 15(32): 3739-3750, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31664864
10.
Extracorporeal portosystemic shunt in secondary Budd-Chiari syndrome.
J Hepatol
; 73(4): 974-976, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32684366
11.
Langerhans cell histiocytosis involving the temporal bone with destruction and subsequent reossification of the bony labyrinth boundaries.
Rofo
; 2024 Feb 19.
Article
in English
| MEDLINE | ID: mdl-38373712
12.
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
J Clin Oncol
; : JCO2301983, 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38657187
13.
Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation.
Immunol Invest
; 42(1): 18-35, 2013.
Article
in English
| MEDLINE | ID: mdl-23083129
14.
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma.
Adv Ther
; 40(9): 3610-3619, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37434067
15.
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.
Adv Ther
; 40(9): 3620-3625, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37438555
16.
Enfortumab vedotin as a salvage option as 5th line therapy for metastatic urothelial bladder cancer.
Aktuelle Urol
; 2023 Nov 14.
Article
in English
| MEDLINE | ID: mdl-37963579
17.
Valuing vicinity: Memory attention framework for context-based semantic segmentation in histopathology.
Comput Med Imaging Graph
; 107: 102238, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37207396
18.
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicity.
Cancer Med
; 12(8): 9373-9383, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36794673
19.
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer.
J Cancer Res Clin Oncol
; 149(15): 14035-14043, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37548775
20.
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome.
Eur J Cancer
; 181: 145-154, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36657323